Literature DB >> 18029035

Involvement of Ymer in suppression of NF-kappaB activation by regulated interaction with lysine-63-linked polyubiquitin chain.

Miyuki Bohgaki1, Tadasuke Tsukiyama, Ayako Nakajima, Satoru Maruyama, Masashi Watanabe, Takao Koike, Shigetsugu Hatakeyama.   

Abstract

It is known that the cytoplasmic zinc finger protein A20 functionally dampens inflammatory signals and apoptosis via inhibition of NF-kappaB activation and biochemically acts as a unique ubiquitin-modifying protein with deubiquitinating activity and ubiquitin ligase activity. However, the molecular mechanisms of A20-modulated signal transduction that influence normal immune responses or tumor immunity have not been fully elucidated. Using a yeast two-hybrid system to search for proteins interacting with A20, we identified one novel binding protein, Ymer. Ymer, which has been reported to be highly phosphorylated on tyrosine residues via EGF stimulation, bound to lysine (K)-63-linked polyubiquitin chain on receptor-interacting serine/threonine-protein kinase 1 (RIP1), which is essential for NF-kappaB signaling in collaboration with A20. A luciferase assay showed that NF-kappaB signaling was down-regulated by overexpression of Ymer, whereas knock-down of Ymer up-regulated NF-kappaB signaling even without stimulation. These findings demonstrate that Ymer is likely to be a negative regulator for the NF-kappaB signaling pathway.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18029035     DOI: 10.1016/j.bbamcr.2007.09.006

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  17 in total

Review 1.  TNF biology, pathogenic mechanisms and emerging therapeutic strategies.

Authors:  George D Kalliolias; Lionel B Ivashkiv
Journal:  Nat Rev Rheumatol       Date:  2015-12-10       Impact factor: 20.543

2.  Ymer acts as a multifunctional regulator in nuclear factor-κB and Fas signaling pathways.

Authors:  Tadasuke Tsukiyama; Mayuko Matsuda-Tsukiyama; Miyuki Bohgaki; Sayuri Terai; Shinya Tanaka; Shigetsugu Hatakeyama
Journal:  Mol Med       Date:  2012-05-09       Impact factor: 6.354

Review 3.  Regulation of NF-κB by deubiquitinases.

Authors:  Edward W Harhaj; Vishva M Dixit
Journal:  Immunol Rev       Date:  2012-03       Impact factor: 12.988

Review 4.  Regulation of NF-κB signaling by the A20 deubiquitinase.

Authors:  Noula Shembade; Edward W Harhaj
Journal:  Cell Mol Immunol       Date:  2012-02-20       Impact factor: 11.530

Review 5.  Deubiquitinases in the regulation of NF-κB signaling.

Authors:  Edward W Harhaj; Vishva M Dixit
Journal:  Cell Res       Date:  2010-11-30       Impact factor: 25.617

6.  A20 reduces lipid storage and inflammation in hypertrophic adipocytes via p38 and Akt signaling.

Authors:  Luoyan Ai; Xiaohan Wang; Zhiwei Chen; Qing Lin; Dazhi Su; Qingqing Xu; Changwei Wu; Xiaoke Jiang; Antao Xu; Zhuping Fan
Journal:  Mol Cell Biochem       Date:  2016-07-22       Impact factor: 3.396

7.  ALIX is a Lys63-specific polyubiquitin binding protein that functions in retrovirus budding.

Authors:  Dara P Dowlatshahi; Virginie Sandrin; Sandro Vivona; Thomas A Shaler; Stephen E Kaiser; Francesco Melandri; Wesley I Sundquist; Ron R Kopito
Journal:  Dev Cell       Date:  2012-11-29       Impact factor: 12.270

8.  The ubiquitin-editing enzyme A20 requires RNF11 to downregulate NF-kappaB signalling.

Authors:  Noula Shembade; Kislay Parvatiyar; Nicole S Harhaj; Edward W Harhaj
Journal:  EMBO J       Date:  2009-01-08       Impact factor: 11.598

9.  Inhibitory feedback control of NF-κB signalling in health and disease.

Authors:  Jack A Prescott; Jennifer P Mitchell; Simon J Cook
Journal:  Biochem J       Date:  2021-07-16       Impact factor: 3.857

10.  Identification of common differentially expressed genes in urinary bladder cancer.

Authors:  Apostolos Zaravinos; George I Lambrou; Ioannis Boulalas; Dimitris Delakas; Demetrios A Spandidos
Journal:  PLoS One       Date:  2011-04-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.